Differences

This shows you the differences between two versions of the page.

--- home:othertreatments:salvestrols [01.03.2012] – external edit 127.0.0.1
+++ home:othertreatments:salvestrols [04.25.2017] – [Notes and comments] sallieq
@@ Line 10: / Line 10: @@
 ===== Curative treatments must generate immunopathology =====
-<html><div class="mainarticle">Main section:</html> [[home:protocol:olmesartan#vitamin_d_receptor_agonist|Vitamin D Receptor agonist]] </article>
+<html><div class="mainarticle">Main section:</html> [[home:protocol:olmesartan#vitamin_d_receptor_agonist|Vitamin D Receptor agonist]]
 According to the Marshall Pathogenesis, patients must generate immunopathology in order to recover from chronic inflammatory disease. To this end, regular dosing of olmesartan (Benicar) is critical. Olmesartan's action as a VDR agonist allows Marshall Protocol patients to activate their innate immune response. This is evident in patients taking MP antibiotics who do not begin killing bacteria until they take olmesartan.
@@ Line 20: / Line 20: @@
 ===== Notes and comments =====
 GETCONTENT
+--- //Sallie Q 04.26.2017//
+from wikipedia
+" A 2007 BBC News story reported on a laboratory study that had found salvestrols extracted from tangerine peel show anti-cancer effects... on cells ..in the laboratory"
+"Enthusiasm for resveratrol, the first salvestrol discovered, decreased substantially with additional scientific investigation. A large clinical trial of a resveratrol-based pharmaceutical, SRT-501, was halted when it showed no anti-cancer activity and had significant side effects...
+... In a 2013 Royal Society of Chemistry podcast, Philip Broadwith stated that "despite the lack of reliable data on resveratrol's effects in humans, the compound is still marketed as a dietary health supplement"

home/othertreatments/salvestrols.txt · Last modified: 09.14.2022 by 127.0.0.1